Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53 EUR | -0.93% | +7.29% | +42.47% |
Jul. 03 | Lonza Group Names New CEO | MT |
Jul. 02 | Lonza Group AG Announces CEO Changes | CI |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With an expected P/E ratio at 42.65 and 33.97 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Sector: Biotechnology & Medical Research
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+42.47% | 41.84B | - | ||
+22.10% | 46.55B | B- | ||
-3.12% | 40.84B | B | ||
+36.10% | 32.95B | B | ||
-6.30% | 28.27B | C | ||
+18.71% | 27.78B | B- | ||
+46.15% | 14.26B | B+ | ||
+44.52% | 13.69B | C+ | ||
+0.19% | 12.18B | B+ | ||
-8.55% | 11.14B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- LONN Stock
- LO3A Stock
- Ratings Lonza Group AG